Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Stüve

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
Annals of Neurology|June 28, 2006
Statins and the blood-brain barrier: plugging the holesOlaf Stüve
JAMA Neurology|June 9, 2015
In Memoriam: Jean Lindenmann (1924-2015): A Circuitous Interfering Power in NeurologyOlaf Stüve
Journal of the Neurological Sciences|January 29, 2010
Knowns and unknowns in the future of multiple sclerosis treatmentOlaf Stüve
Archives of Neurology|June 12, 2013
The cradle of american neurology: the harvard neurological unit at the Boston city hospitalOlaf Stüve
Journal of the Neurological Sciences|May 14, 2008
The effects of natalizumab on the innate and adaptive immune system in the central nervous systemOlaf Stüve
Cold Spring Harbor Perspectives in Medicine|March 4, 2018
Natalizumab: Perspectives from the Bench to BedsideAfsaneh Shirani, Olaf Stüve
Neurology|September 25, 2009
Iatrogenic immunosuppression with biologics in MS: expecting the unexpected?Olaf Stüve, Heinz Wiendl
Therapeutic Advances in Neurological Disorders|October 25, 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis?Bardia Nourbakhsh, Olaf Stüve
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
The genetics of natalizumab hypersensitivity: One learns to itch where one can scratchOlaf Stüve, Bernhard Hemmer
JAMA Neurology|February 10, 2015
Treatment decisions for patients with active multiple sclerosisOlaf Stüve, Diego Centonze
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
Annals of Neurology|June 28, 2006
Statins and the blood-brain barrier: plugging the holesOlaf Stüve
JAMA Neurology|June 9, 2015
In Memoriam: Jean Lindenmann (1924-2015): A Circuitous Interfering Power in NeurologyOlaf Stüve
Journal of the Neurological Sciences|January 29, 2010
Knowns and unknowns in the future of multiple sclerosis treatmentOlaf Stüve
Archives of Neurology|June 12, 2013
The cradle of american neurology: the harvard neurological unit at the Boston city hospitalOlaf Stüve
Journal of the Neurological Sciences|May 14, 2008
The effects of natalizumab on the innate and adaptive immune system in the central nervous systemOlaf Stüve
Cold Spring Harbor Perspectives in Medicine|March 4, 2018
Natalizumab: Perspectives from the Bench to BedsideAfsaneh Shirani, Olaf Stüve
Neurology|September 25, 2009
Iatrogenic immunosuppression with biologics in MS: expecting the unexpected?Olaf Stüve, Heinz Wiendl
Therapeutic Advances in Neurological Disorders|October 25, 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis?Bardia Nourbakhsh, Olaf Stüve
Neurology(R) Neuroimmunology & Neuroinflammation|December 19, 2014
The genetics of natalizumab hypersensitivity: One learns to itch where one can scratchOlaf Stüve, Bernhard Hemmer
JAMA Neurology|February 10, 2015
Treatment decisions for patients with active multiple sclerosisOlaf Stüve, Diego Centonze
Pageof 20